Human parvovirus B19 infection in multiple sclerosis

European Neurology

Volumn 42, Issue 1, 1999, Pages 36-40

  Nakashima, Ichiro ^a   Fujihara, Kazuo ^a   Itoyama, Yasuto ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Enzyme linked immunosorbent assay; Multiple sclerosis; Parvovirus B19; Polymerase chain reaction

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ANTIBODY TITER; ARTICLE; CEREBROSPINAL FLUID EXAMINATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; MALE; MULTIPLE SCLEROSIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REMISSION;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; CHILD; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; JAPAN; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PARVOVIRIDAE INFECTIONS; PARVOVIRUS; POLYMERASE CHAIN REACTION;

EID: 0032979968     PISSN: 00143022     EISSN: None     Source Type: Journal    
DOI: 10.1159/000008066     Document Type: Article

References (15)

1. Anderson LJ: Human parvoviruses. J Infect Dis 1990;161:603-608.
2. Fawaz-Estrup F: Human parvovirus infection: Rheumatic manifestations, angioedema, Cl esterase inhibitor deficiency, ANA appearance, and possible onset of systemic lupus erythematosus. J Rheumatol 1996;23:1180-1185.
3. Soloninka CA, Anderson MJ, Laskin CA: Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol 1989;16:777-781.
4. Wagner AD, Goronzy JJ, Matteson EL, Weyand CM: Systemic monocyte and T-cell activation in a patient with human parvovirus B19 infection. Mayo Clin Proc 1995;70:261-265.
5. Watanabe T, Satoh M, Oda Y: Human parvovirus B19 encephalopathy. Arch Dis Child 1994;70:71.
6. Okumura A, Ichikawa T: Aseptic meningitis caused by human parvovirus B19. Arch Dis Child 1993;68:784-785.
7. Durigon EL, Erdman DD, Gary W, Pallansch MA, Torok TJ, Anderson LJ: Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA. J Virol Methods 1993;44:155-165.
8. Shade RO, Blundell MC, Cotmore SF, Tattersall P, Astell CR: Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 1986;58:921-936.
9. Cook SD, Rohowsky-Kochan C, Bansil S, Dowling PC: Evidence for a viral etiology of multiple sclerosis; in Cook SD (ed): Handbook of Multiple Sclerosis. New York, Dekker, 1996, PP 97-118.
10. Fujinami RS, Oldstone MB: Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985;230:1043-1045.
11. Alvord EC Jr, Jahnke U, Fischer EH, Kies MW, Driscoll BF, Compston DA: The multiple causes of multiple sclerosis: The importance of infections in childhood. J Child Neurol 1987;2: 313-321.
12. Nikkari S, Roivainen A, Hannonen P, Möttönen T, Luukkainen R, Yli-Jama T: Persistence of parvovirus B19 in synovial fluid and bone marrow. Ann Rheum Dis 1995;54:597-600.
13. Haseyama K, Kudoh T, Yoto Y, Suzuki N, Chiba S: Detection of human parvovirus B19 DNA in cerebrospinal fluid. Pediatr Infect Dis J 1997;16:324-325.
14. Collard RC, Koehler RP, Mattson DH: Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology 1997; 49:857-861.
15. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW: New diagnostic criteria for multiple sclerosis: Guidelines for research protocols. Ann Neurol 1983;13:227-231.